Ethnobotanical indicator values of Non-Timber Forest Products from the Djoumouna peri-urban forest in Brazzaville, Republic of Congo.

A study of the relationship between man and his environment was carried out in Brazzaville, Republic of Congo in the peri-urban forest of Djoumouna. Socio-economic and ethnobotanical surveys conducted among the human populations in riparian areas were supported by direct field observations and a review of the literature. Data were collected from a 2 km zone of influence around the Djoumouna forest. The group of survey participants, organized into four age groups, included all socio-professional categories and was made up of 143 heads of household. The survey participants were of both genders and ranged in age from 15 to over 45 years old. Ethnobotanical indicators were used as data analysis tools, specifically, ethnobotanical use-value, survey participant consensus factor, and level of fidelity. This study identified 13 plant species and more than 14 animal taxa as Non-Timber Forest Products (NTFPs) of animal and plant origin. Most of the taxa listed are used in traditional foods and/or phytotherapy. The low values of some ethnobotanical indicators show that these NTFPs, which are not highly sought after and valued by the population, are also rare in this peri-urban ecosystem. This observation is also valid when considering the involvement of survey participants by age group. However, the survey participant consensus factor reflects a unanimity of traditional exploitation of these NTFPs within the society. The analysis of the ethnobotanical data clearly show a difference in the level of exploitation of NTFPs between genders with men having more interest in finding and using NTFPs. Finally, the study indicates (i) gender specialization is associated with NTFP activities and exploitation, and (ii) a progressive erosion of traditional knowledge is occurring between age groups.

Neural and humoral changes associated with the adjustable gastric band: insights from a rodent model.

BACKGROUND: Bariatric surgical procedures, including the laparoscopic adjustable gastric band (LAGB), are currently the only effective treatments for morbid obesity, however, there is no clear understanding of the mechanisms underpinning the efficacy of LAGB. The aim of this study is to examine changes in activation of the sensory neuronal pathways and levels of circulating gut hormones associated with inflation of an AGB. DESIGN AND RESULTS: The trajectory within the central nervous system of polysynaptic projections of sensory neurons innervating the stomach was determined using the transsynaptically transported herpes simplex virus (HSV). Populations of HSV-infected neurons were present in the brainstem, hypothalamus and cortical regions associated with energy balance. An elevation of Fos protein was present within the nucleus of the solitary tract, a region of the brainstem involved in the control of food intake, following acute and chronic band inflation. Two approaches were used to test (1) the impact of inflation of the band alone (on a standard caloric background) or (2) the impact of a standard caloric meal (on the background of the inflated band) on circulating gut hormones. Importantly, there was a significant elevation of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY) following oral gavage of a liquid meal in animals with pre-inflated bands. There was no impact of inflation of the band alone on circulating GLP-1, PYY or ghrelin in animals on a standard caloric background. CONCLUSION: These data are consistent with the notion that the LAGB exerts its effects on satiety, reduced food intake and reduced body weight by the modulation of both neural and hormonal responses with the latter involving an elevation of meal-related levels of GLP-1 and PYY. These data are contrary to the view that the surgery is purely 'restrictive'.

An anatomic basis for the communication of hypothalamic, cortical and mesolimbic circuitry in the regulation of energy balance.

Central neural control of complex feeding behaviour is likely to be influenced by a number of factors including homeostatic responses to peripheral nutrient status, cortical integration of feeding-related cues and the underlying reward value of food. We have used retrogradely transported neurotropic viruses, as tools to map chains of synaptically-connected neurons, in conjunction with neurochemical markers of feeding-related peptides to expand the blueprint of the circuitries that underlie these different components of feeding behaviour. We have identified projections to insular and anterior cingulate cortex, extending from the arcuate nucleus through synaptic relays in the lateral hypothalamic area and midline thalamic nuclei. Cortically projecting neurons from the hypothalamic arcuate nucleus were found predominantly in its lateral aspects and contained anorexigenic peptides with no representation amongst more medially-positioned neurons containing orexigenic peptides. Largely overlapping pathways were shown to project multisynaptically to the shell of the nucleus accumbens but those with origins in the arcuate nucleus had either orexigenic or anorexigenic phenotypes. Similar to the cortical projections, those relaying to the nucleus accumbens in the lateral hypothalamus contained the orexigenic peptides orexin-A and melanin-concentrating hormone in approximately 30% of cases. Common to the neural pathways directed to all three virally-injected areas were nodes of synaptic relays in the lateral hypothalamus and midline thalamic nuclei. These regions are well positioned to integrate sensory information about energy homeostasis and the reward value of food in the passage of this information to the 'ingestive cortex'.

A rodent model of adjustable gastric band surgery-implications for the understanding of underlying mechanisms.

BACKGROUND: Bariatric surgery is currently the only anti-obesity therapy that can deliver weight loss of up to 20-30% of body weight. Laparoscopic adjustable gastric banding (LAGB) and Roux-en-y gastric bypass are the most commonly performed of these surgeries. The mechanisms by which LAGB initiates an increase in satiety remain completely unknown. The aim of this study is to establish a rodent model of adjustable gastric banding (AGB) that will enable investigation of these mechanisms. METHODS: Sprague-Dawley rats were implanted with adjustable gastric bands immediately below the gastro-esophageal junction around the glandular stomach. This band, as in humans, can be inflated via an exteriorized port resulting in an incremental impact on the stomach. RESULTS: Rats with an incremental inflation of the AGB showed a clear stepwise reduction in food intake and body weight. Normal food intake and body weight gain were restored with band deflation. Barium-assisted X-ray of the stomach showed the formation of a small gastric pouch proximal to the inflated band in a manner analogous to the human LAGB. CONCLUSIONS: This is the first animal model of the AGB that allows incremental inflation for optimal tightening of the band in the conscious animal with corresponding effects on food intake and body weight. This model will allow measurement of acute and chronic neural and hormonal changes following activation of the band in the conscious animal and will provide the potential to inform and improve surgical approaches that are at the forefront of obesity treatments.

Effect of human body weight changes on circulating levels of peptide YY and peptide YY3-36.

BACKGROUND: Recent findings suggest that low plasma peptide YY (PYY) levels may contribute to diet-induced human obesity and justify PYY replacement therapy. Although the pharmacological value of PYY is controversial, further study of the secretion of the precursor PYY(1-36) and the pharmacologically active PYY(3-36) is indicated to determine the potential role in energy balance regulation. AIM: Our objective was to determine the effects of acute and chronic changes in human body weight on circulating levels of the putative satiety hormone peptide YY. DESIGN: Total plasma PYY levels (PYY(1-36) + PYY(3-36)) were measured in 66 lean, 18 anorectic, 63 obese, and 16 morbidly obese humans. In addition, total PYY was measured in 17 of the obese patients after weight loss and in the 18 anorectic patients after weight gain. Fasting PYY(3-36) levels were measured in 17 lean and 15 obese individuals. RESULTS: Fasting total plasma PYY levels were highest in patients with anorexia nervosa (80.9 +/- 12.9 pg/ml, P < 0.05) compared with lean (52.4 +/- 4.6 pg/ml), obese (43.9 +/- 3.8 pg/ml), or morbidly obese (45.6 +/- 11.2 pg/ml) subjects. In obese patients, weight loss of 5.4% was associated with a 30% decrease in fasting total PYY plasma levels. In anorectic patients, weight gain had no effect on fasting PYY. PYY(3-36) levels did not differ between lean (96.2 +/- 8.6 pg/ml) and obese (91.5 +/- 6.9 pg/ml) subjects. CONCLUSION: Our findings do not support a role for abnormal circulating PYY in human obesity. We conclude that circulating PYY levels in humans are significantly elevated in anorexia nervosa and, given the controversially discussed anorectic effect of PYY, could theoretically contribute to that syndrome.

Effect of central administration of QRFP(26) peptide on energy balance and characterization of a second QRFP receptor in rat.

The recently identified neuropeptide QRFP(26) is predominantly expressed in the hypothalamus and was suggested to play a role in the regulation of food intake following the observation of an acute orexigenic effect after central administration in mice. QRFP(26) exerts its effect via GPR103 and a newly identified receptor in mouse. The aim of our study was (a) to investigate the distribution of QRFP(26) and a newly discovered QRFP receptor mRNA in rat and (b) to further characterize the effects of central administration of QRFP(26) on energy balance in rats. QRFP(26) mRNA was detected in the retrochiasmatic nucleus, periventricular nucleus, arcuate nucleus and restricted areas of the lateral nucleus of the hypothalamus. We found an additional receptor with high homology for GPR103 in rat. This receptor increases inositol triphosphate production in transfected cells in presence of QRFP(26) and its mRNA was particularly enriched in ventral and posterior thalamic groups, anterior hypothalamus and medulla. When QRFP(26) (10 microg and 50 microg) was administered centrally before the start of the light phase both doses increased food intake for 2 h after injection without reaching statistical significance. QRFP(26) caused no changes in locomotor activity or energy expenditure. In summary, central QRFP(26) injection causes slight and transient hyperphagia in rats without changing any other energy balance parameters after 24 h. We conclude that QRFP(26) has limited impact on the central regulation of energy balance in rats and that its essential function remains to be clarified.